CAS No.24305-27-9,Protirelin Suppliers

Products Categories

Pharmaceutical (149)
Organic Chemicals (34)
Others (16)
Plant Extract (3)
Materials (3)
Reagent (1)

Basic Information

Molecular Structure:
CAS No.:	24305-27-9
Name:	Protirelin
Article Data:	44

Formula:	C₁₆H₂₂N₆O₄
Molecular Weight:	362.388
Synonyms:	Abbott 38579;Abbott-38579;Abbott38579;Antepan;Hydrate, Proterelin Tartrate;Prem, TRH;Proterelin Tartrate;Proterelin Tartrate Hydrate;Protirelin;Protirelin Tartrate (1:1);Relefact TRH;Stimu TSH;Stimu-TSH;StimuTSH;Tartrate Hydrate, Proterelin;Thypinone;Thyroliberin;Thyroliberin TRH Merck;Thyrotropin Releasing Factor;Thyrotropin Releasing Hormone;Thyrotropin Releasing Hormone Tartrate;Thyrotropin-Releasing Factor;Thyrotropin-Releasing Hormone;Thyrotropin-Releasing Hormone Tartrate;TRH Ferring;TRH Prem;TRH, Relefact
EINECS:	246-143-4
Density:	1.421 g/cm³
Boiling Point:	978.4 °C at 760 mmHg
Flash Point:	545.5 °C
Solubility:	10 mg/mL in water
Appearance:	COA
Safety:	22-24/25
PSA:	144.49000
LogP:	-0.55120

Raw Materials

98-79-3

71-00-1

Total:121 Page 1 of 4 1 2 3 4 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 24305-27-9

Specification

Protirelin is one kind of white powder. The IUPAC Name of this chemical is (2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide. Besides, Protirelin belongs to Peptide. Protirelin can soluble in water whose solubility is 10 mg/mL in water.

Physical properties about Protirelin are: (1)ACD/LogP: -3.011; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): -4.51; (4)ACD/LogD (pH 7.4): -3.17; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 10; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 6; (12)Index of Refraction: 1.615; (13)Molar Refractivity: 88.974 cm³; (14)Molar Volume: 254.851 cm³; (15)Polarizability: 35.272 10-24cm³; (16)Surface Tension: 74.859001159668 dyne/cm; (17)Density: 1.422 g/cm³; (18)Flash Point: 545.494 °C; (19)Enthalpy of Vaporization: 142.758 kJ/mol; (20)Boiling Point: 978.363 °C at 760 mmHg

Uses of Protirelin: Protirelin(CAS NO.24305-27-9) inspired the role of anterior pituitary secretion of thyroid-stimulating hormone and cause the release of prolactin. Used in biochemical research and clinical diagnosis of hypothalamic-pituitary-thyroid dysfunction in a reference indicator.

You can still convert the following datas into molecular structure:
(1)InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12+/m0/s1;
(2)InChIKey=XNSAINXGIQZQOO-SDDRHHMPSA-N;
(3)SmilesN1([C@@H](CCC1)C(N)=O)C([C@@H](Cc1c[nH]cn1)NC([C@@H]1CCC(N1)=O)=O)=O;

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
man	TDLo	intravenous	5333ng/kg/2M- (.005333mg/kg)	BEHAVIORAL: COMA VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION	British Medical Journal. Vol. 287, Pg. 532, 1983.
man	TDLo	intravenous	5714ng/kg/1M- (.005714mg/kg)	LUNGS, THORAX, OR RESPIRATION: DYSPNEA CARDIAC: PULSE RATE BEHAVIORAL: COMA	Medical Journal of Australia. Vol. 143, Pg. 264, 1985.
mouse	LD50	intravenous	921mg/kg (921mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
mouse	LD50	oral	> 10gm/kg (10000mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
mouse	LD50	subcutaneous	> 20gm/kg (20000mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
rat	LD50	intravenous	514mg/kg (514mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
rat	LD50	oral	> 5gm/kg (5000mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
rat	LD50	subcutaneous	> 10gm/kg (10000mg/kg)		Drugs in Japan Vol. 6, Pg. 727, 1982.
women	TDLo	intravenous	8ug/kg/2M-C (.008mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP	British Medical Journal. Vol. 287, Pg. 532, 1983.